Vineet Laboratories Ltd.
| BSE: 543298 | Sector: Health care |
| NSE: VINEETLAB | ISIN Code: INE505Y01010 |
| BSE 00:00 | 03 Feb | 54.05 |
-1.30 (-2.35%) |
OPEN
57.05 |
HIGH
57.05 |
LOW
51.95 |
| NSE 00:00 | 03 Feb | 54.25 |
-0.60 (-1.09%) |
OPEN
55.65 |
HIGH
56.65 |
LOW
51.80 |
| OPEN | 57.05 |
| PREVIOUS CLOSE | 55.35 |
| VOLUME | 15857 |
| 52-Week high | 81.85 |
| 52-Week low | 47.35 |
| P/E | 52.48 |
| Mkt Cap.(Rs cr) | 50 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Vineet Laboratories Ltd. (VINEETLAB) - Net Profit
Net Profit
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Profit (Rs crore) |
| Cipla | 1023.00 | -1.95 | -0.19 | 2957.93 |
| Divi's Lab. | 2884.45 | -382.70 | -11.71 | 2948.54 |
| Glenmark Pharma. | 385.80 | -3.45 | -0.89 | 1997.79 |
| Glaxosmi. Pharma | 1245.00 | 9.55 | 0.77 | 1690.53 |
| Dr Reddy's Labs | 4357.90 | -12.15 | -0.28 | 1623.20 |
| Alkem Lab | 3052.60 | -22.00 | -0.72 | 1541.25 |
| Aurobindo Pharma | 403.90 | -6.00 | -1.46 | 1454.71 |
| Gland Pharma | 1213.30 | -62.65 | -4.91 | 1212.16 |
| Torrent Pharma. | 1532.20 | -8.50 | -0.55 | 991.45 |
| Sanofi India | 5358.55 | -58.30 | -1.08 | 944.40 |
| Ipca Labs. | 855.50 | -1.00 | -0.12 | 870.94 |
| Zydus Lifesci. | 434.00 | 1.40 | 0.32 | 857.90 |
| Abbott India | 20867.55 | 383.40 | 1.87 | 798.70 |
| Laurus Labs | 331.20 | -7.60 | -2.24 | 750.09 |
| Ajanta Pharma | 1175.15 | -14.40 | -1.21 | 719.86 |
| Apollo Hospitals | 4244.75 | 11.75 | 0.28 | 665.20 |
| Pfizer | 3872.35 | 19.30 | 0.50 | 612.56 |
| Suven Pharma | 484.65 | -3.55 | -0.73 | 558.10 |
| Alembic Pharma | 535.25 | -4.95 | -0.92 | 543.55 |
| Glenmark Life | 376.50 | -3.90 | -1.03 | 418.72 |
Quick Links for Vineet Laboratories:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
